financing characteristics

Immunovant Announces Pricing of $550 Million Common Stock Financing

1 month ago talkbio0Tagged Capital, equity financing, financing characteristics, Immunovant, IMVT, IMVT-1402, Leerink Partners, Roivant Sciences

Immunovant; IMVT; common stock offering; $550 million financing; equity financing; underwritten offering; IMVT-1402; Roivant Sciences; Leerink Partners; biotech capital raise

Apple Tree files for bankruptcy as it seeks fresh funding from Russian billionaire backer

1 month ago talkbio0Tagged backer, Bankruptcy filing, debt obligations, financing characteristics, insolvency, investor rescue, Malus domestica, restructuring, Russian language

Apple Tree; bankruptcy filing; insolvency; Russian billionaire backer; restructuring; financing deal; debt obligations; investor rescue

BridgeBio Oncology Therapeutics: Recent News Overview (November 2025)

2 months ago talkbio0Tagged AACR-NCI-EORTC, BridgeBio Oncology Therapeutics, clinical-stage biopharma, de-SPAC transaction, financial results, financing characteristics, Helix Acquisition Corp II, PI3Kδ, Piperine Extract (Standardized), ras Oncogene, third quarter 2025

BridgeBio Oncology Therapeutics; Helix Acquisition Corp II; de-SPAC transaction; PIPE financing; RAS and PI3Kα; clinical-stage biopharma; AACR-NCI-EORTC Conference; third quarter 2025 financial results

Eli Lilly to Acquire Adverum Biotechnologies in Gene Therapy Deal; Captain T Cell Secures €20M Funding

2 months ago talkbio0Tagged Acquisition, Adverum Biotechnologies, biotech, Captain T Cell, contingent value rights, CVR, eli lilly, financing characteristics, gene therapy, Investments, Ixo-vec, Ophthalmology specialty

Eli Lilly; Adverum Biotechnologies; Acquisition; Gene therapy; Ixo-vec; Contingent Value Rights (CVR); Ophthalmology; Captain T Cell; Financing; Biotech investment